Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

2.5K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
Odds Ratio01:09

Odds Ratio

2.3K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
2.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Hazard Ratio01:12

Hazard Ratio

756
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
756
Hazard Rate01:11

Hazard Rate

525
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
525
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

792
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
792

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Soft Bayesian Additive Regression Trees (SBART) for correlated survey response with non-Gaussian error.

Journal of nonparametric statistics·2026
Same author

Identification of a robust metabolic signature associated with hospital-acquired pneumonia and response to interferon-gamma treatment in critically ill patients.

Critical care (London, England)·2026
Same author

A gene-expression module identifies circulating immune cells with enhanced recruitment to sites of inflammation.

iScience·2026
Same author

Lucian Leape's legacy for patient safety.

BMJ quality & safety·2026
Same author

Macrophage MR1 antigen presentation promotes MAIT cell immunity and lung microbiota modulation.

Science (New York, N.Y.)·2025
Same author

A practical overview and statistical analysis of interval-censored data in cancer.

Cancer communications (London, England)·2025
Same journal

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026
Same journal

Towards optimal environmental policies: policy learning under arbitrary bipartite network interference.

Biostatistics (Oxford, England)·2026
Same journal

Multilevel functional quantile principal component analysis.

Biostatistics (Oxford, England)·2026
Same journal

Adaptive transfer learning for time-to-event modeling with applications in disease risk assessment.

Biostatistics (Oxford, England)·2026
Same journal

High-dimensional test for one-sided hypotheses.

Biostatistics (Oxford, England)·2026
Same journal

NBSR: a Negative Binomial Softmax Regression model for microRNA-seq data analysis.

Biostatistics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Almost efficient estimation of relative risk regression.

Garrett M Fitzmaurice1, Stuart R Lipsitz2, Alex Arriaga2

  • 1Harvard Medical School, Boston, MA 02115, USA fitzmaur@hsph.harvard.edu.

Biostatistics (Oxford, England)
|April 8, 2014
PubMed
Summary
This summary is machine-generated.

Researchers developed a new method for estimating relative risks (RRs) in log-binomial regression, overcoming numerical instability and convergence issues common in standard maximum likelihood estimation. This approach provides a more stable and efficient way to analyze prospective studies with common binary outcomes.

Keywords:
Bernoulli likelihoodConvergence problemsMaclaurin seriesPoisson regressionQuasi-likelihood

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Related Experiment Videos

Last Updated: May 1, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Statistical Modeling

Background:

  • Relative risks (RRs) are preferred in prospective studies for common binary outcomes due to intuitive interpretation over odds ratios.
  • Log-binomial regression, while a special case of generalized linear models, faces numerical instability and convergence problems because it doesn't constrain predicted probabilities within the [0,1] range.
  • Existing alternative methods, like Poisson regression estimating equations, provide consistent but inefficient estimators for RR regression parameters.

Purpose of the Study:

  • To address the numerical instability and convergence issues in maximum likelihood estimation for log-binomial regression.
  • To develop an almost efficient and stable estimator for relative risk regression parameters.
  • To compare the efficiency of the proposed estimator against existing methods, including Poisson regression.

Main Methods:

  • Proposed an alternative estimator for RR regression parameters using near-optimal weights derived from a Maclaurin series approximation.
  • Investigated the asymptotic relative efficiency of the proposed estimator with increasing terms in the series.
  • Utilized simulation studies to demonstrate convergence problems with standard maximum likelihood estimation and the efficacy of the proposed method.

Main Results:

  • Standard maximum likelihood estimation in log-binomial regression is prone to convergence problems.
  • The proposed method, using Maclaurin series approximation for weights, yields an almost efficient estimator that avoids convergence issues.
  • Simulations confirmed the potential for convergence problems and the successful resolution using the proposed estimator.

Conclusions:

  • The developed method offers a stable and efficient alternative for estimating relative risks in log-binomial regression.
  • This approach effectively circumvents the convergence problems associated with standard maximum likelihood estimation.
  • The proposed estimator is applicable to real-world epidemiological studies, as demonstrated in an analysis of pre-operative beta-blocker use in colorectal surgery patients.